Compare Globalstar (GSAT) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs Heron Therapeutics Inc — how do they compare? Globalstar trades at $83.82 (market cap $10.78B), while Heron Therapeutics Inc trades at $0.41 (market cap $68.01M). The key difference: Globalstar is far larger — about 158.5× Heron Therapeutics Inc's market cap, and Globalstar is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 21 Days and Heron Therapeutics Inc for 35 Days on average.
| GSAT | HRTX | |
|---|---|---|
Market Cap | $10.78B | $68.01M |
Volume | 723,953 | 1,891,941 |
Sector | Media | Health |
52-Week High | $84.43 | $1.49 |
52-Week Low | $41.54 | $0.27 |
Typical Hold Time | 21 Days | 35 Days |
Enterprise Value | $10.79B | $174.75M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.3582, down 8.15% today, with a bullish technical signal from moving averages but mixed earnings. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates, continuing a trend of net losses. Analyst sentiment remains strongly positive with 89% buy ratings, though Zacks issued a Strong Sell rating in July 2026.
The outlook hinges on revenue stabilization and path to profitability. Investment opportunity lies in analyst optimism and product sales growth, but risks include persistent losses, high valuation multiples, and competitive pressures in the biotechnology sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
